Literature DB >> 21041284

Delayed puberty due to a novel mutation in CHD7 causing CHARGE syndrome.

Andrew Dauber1, Joel N Hirschhorn, Jonathan Picker, Thomas A Maher, Aubrey Milunsky.   

Abstract

We report the case of a 15-year-old girl who presented to a pediatric endocrinology clinic for delayed puberty with no signs of secondary sexual development. Her past medical history was significant for bilateral colobomas, inner-ear anomalies, hearing loss, and anosmia. Genetic testing revealed a novel de novo mutation in the CHD7 gene, one of the causative genes in CHARGE syndrome (coloboma, heart disease, choanal atresia, retarded growth and development and/or central nervous system anomalies, genital anomalies and/or hypogonadism, and ear anomalies and/or deafness). We review the distinction between hypogonadotrophic hypogonadism and hypergonadotrophic hypogonadism and discuss the availability of molecular genetic testing for idiopathic hypogonadotrophic hypogonadism. CHD7 mutations have also been found in some patients with Kallmann syndrome, hypogonadotrophic hypogonadism, and anosmia, and we discuss the overlap between this syndrome and CHARGE syndrome. With the increased availability of genetic testing for a variety of disorders, it is important for pediatricians to become familiar with interpreting genetic test results. Finally, we illustrate that Bayes' theorem is a useful statistical tool for interpreting novel missense mutations of unknown significance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21041284     DOI: 10.1542/peds.2010-0164

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  6 in total

1.  Functional Hypogonadotropic Hypogonadism in Men: Underlying Neuroendocrine Mechanisms and Natural History.

Authors:  Andrew A Dwyer; Niraj R Chavan; Hilana Lewkowitz-Shpuntoff; Lacey Plummer; Frances J Hayes; Stephanie B Seminara; William F Crowley; Nelly Pitteloud; Ravikumar Balasubramanian
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

2.  Mutation analyses in pedigrees and sporadic cases of ethnic Han Chinese Kallmann syndrome patients.

Authors:  Wei-Jun Gu; Qian Zhang; Ying-Qian Wang; Guo-Qing Yang; Tian-Pei Hong; Da-Long Zhu; Jin-Kui Yang; Guang Ning; Nan Jin; Kang Chen; Li Zang; An-Ping Wang; Jin Du; Xian-Ling Wang; Li-Juan Yang; Jian-Ming Ba; Zhao-Hui Lv; Jing-Tao Dou; Yi-Ming Mu
Journal:  Exp Biol Med (Maywood)       Date:  2015-06-01

Review 3.  The role of CHD7 and the newly identified WDR11 gene in patients with idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.

Authors:  Hyung-Goo Kim; Lawrence C Layman
Journal:  Mol Cell Endocrinol       Date:  2011-08-02       Impact factor: 4.102

4.  Reversible congenital hypogonadotropic hypogonadism in patients with CHD7, FGFR1 or GNRHR mutations.

Authors:  Eeva-Maria Laitinen; Johanna Tommiska; Timo Sane; Kirsi Vaaralahti; Jorma Toppari; Taneli Raivio
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

Review 5.  Delayed Puberty-Phenotypic Diversity, Molecular Genetic Mechanisms, and Recent Discoveries.

Authors:  Sasha R Howard; Leo Dunkel
Journal:  Endocr Rev       Date:  2019-10-01       Impact factor: 19.871

6.  Identification of a novel mutation in the CHD7 gene in a patient with CHARGE syndrome.

Authors:  Yeonkyung Kim; Ho-Seok Lee; Jung-Seok Yu; Kangmo Ahn; Chang-Seok Ki; Jihyun Kim
Journal:  Korean J Pediatr       Date:  2014-01-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.